Explore Books on
drug accessibility

Politics of the Pharmaceutical Industry and Access to Medicines

By Hans Löfgren

Illicit Medicines in the Global South

By Mathieu Quet

Propiedad intelectual y acceso a medicamentos esenciales de calidad en Centroamérica

By Gerson Elí Martínez

Intellectual property, pharmaceuticals and public health

By Kenneth C. Shadlen

Balancing Wealth and Health

By Rochelle Dreyfuss,César Rodríguez-Garavito

Post-Trial Access to Drugs in Developing Nations

By Evaristus Chiedu Obi

Adequacy of access to investigative drugs for seriously ill patients

By United States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations.

Drug user fees

By United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

Closing the gaps in Hatch-Waxman

By United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.

Recent developments which may impact consumer access to, and demand for, pharmaceuticals

By United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health

FDA drug approval--a lengthy process that delays the availability of important new drugs

By United States. General Accounting Office

Marketing of Clozaril

By United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust, Monopolies, and Business Rights.

Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages

By United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health

Improving predictability and transparency in DEA and FDA regulation

By United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health

Drug shortages

By United States. Congress. Senate. Committee on Finance

L'accès aux médicaments dans les pays en développement

By Elisabeth Chamorand

Promoting access to medical technologies and innovation

By Hans G. Bartels

Compulsory license and "government use" to promote access to medicines

By Martin Khor

The politics of the pharmaceutical industry and access to medicines

By Hans Löfgren

Direito à propriedade intelectual versus saúde pública

By Yasmine Santos Mansur

Short-supply prescription drugs

By United States. Congress. Senate. Committee on Commerce, Science, and Transportation

Prescription drug shortages

By United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions

Examining drug shortages and recent efforts to address them

By United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health

Diplōmata euresitechnias pharmakōn

By Geōrgios N. Kaphetzēs